Spruce Capital Partners and Xeraya Capital Hold First Close of Biogreentech Fund at $150M

Spruce Capital Partners and Xeraya Capital announced the first close of a fund at $150m.

MLS Capital Fund II, L.P., the successor to the $162m Malaysian Life Sciences Capital Fund, is co-managed by Spruce Capital Partners and Xeraya Capital, which will invest the funds in a diversified portfolio of biogreentech companies at all stages of development.

Biogreentech spans plant and animal agriculture; food, feed, and nutrition; bio-renewable chemicals and materials; and adjacent opportunities along the value chain, including “big data analytics”, robotics, production, harvesting and use of natural resources, and synthetic biology.

The fund will have offices in San Francisco and Kuala Lumpur, Malaysia.



Join the discussion